Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-12 Purchase |
2023-05-16 4:05 pm |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
87,000 | $1.1224 | $97,652 | 423,408 (Indirect Direct) |
View |
| 2020-12-02 Sale |
2020-12-02 09:45 am |
BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director |
2,018 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-21 11:05 am |
N/A 2034-06-19 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:45 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:48 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 9:46 pm |
N/A 2033-01-16 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
650,000 | $0 | 883,040 (Direct) |
View |
| 2022-07-25 Exercise(A) |
2022-07-27 1:46 pm |
N/A 2029-04-07 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
100,000 | $0 | 1,378,359 (Direct) |
View |
| 2022-07-25 Exercise(A) |
2022-07-27 1:46 pm |
N/A N/A |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
100,000 | $2.09 | 1,378,359 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-26 9:25 pm |
N/A 2029-04-07 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
100,000 | $0 | 1,275,364 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-26 9:25 pm |
N/A N/A |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
100,000 | $2.09 | 1,275,364 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:39 pm |
N/A 2032-05-31 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
11,600 | $0 | 11,600 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 6:53 pm |
N/A 2032-01-17 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
875,000 | $0 | 875,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 08:07 am |
N/A 2031-05-26 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
23,200 | $0 | 23,200 (Direct) |
View |
| 2021-01-22 Option Award |
2021-01-26 4:40 pm |
N/A 2031-01-21 |
CHIMERIX INC | CMRX | Sherman Michael A. Chief Executive Officer |
700,000 | $0 | 700,000 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-04 6:21 pm |
N/A 2030-05-01 |
BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Sherman Michael A. Director |
6,000 | $0 | 6,000 (Direct) |
View |